Malignant neoplasm of unspecified kidney, except renal pelvis
ICD-10 C64.9 is a billable code used to indicate a diagnosis of malignant neoplasm of unspecified kidney, except renal pelvis.
C64.9 refers to a malignant neoplasm located in the kidney that has not been specified as affecting the renal pelvis. This diagnosis encompasses a variety of kidney cancers, including renal cell carcinoma, which is the most common type. The unspecified nature of the code indicates that the exact type of malignancy has not been determined or documented. Kidney cancers can present with symptoms such as hematuria, flank pain, and weight loss, but may also be asymptomatic in early stages. Staging of kidney cancer is crucial for determining treatment options and prognosis, typically classified using the TNM system (Tumor, Node, Metastasis). Surgical management often involves nephrectomy, either partial or radical, depending on the tumor's size and location. In cases where the cancer is advanced, additional treatments such as targeted therapy or immunotherapy may be indicated. Accurate coding is essential for appropriate treatment planning and reimbursement.
Detailed pathology reports, imaging studies, and treatment plans.
Diagnosis and management of renal cell carcinoma, staging evaluations, and treatment planning.
Ensure accurate documentation of tumor characteristics and staging to support coding.
Surgical reports, pre-operative assessments, and post-operative follow-ups.
Nephrectomy procedures, management of renal masses, and follow-up care.
Document the specifics of the surgical approach and any complications encountered.
Used for surgical management of renal tumors.
Operative report detailing the procedure and findings.
Urologists must document the specifics of the nephrectomy approach.
Document all relevant clinical findings, imaging results, and treatment plans. Ensure that the type of malignancy is clearly stated if known, and provide staging information.
